FR2948026B1 - Derives amines de dihydro-1,3,5-triazine - Google Patents

Derives amines de dihydro-1,3,5-triazine

Info

Publication number
FR2948026B1
FR2948026B1 FR0954976A FR0954976A FR2948026B1 FR 2948026 B1 FR2948026 B1 FR 2948026B1 FR 0954976 A FR0954976 A FR 0954976A FR 0954976 A FR0954976 A FR 0954976A FR 2948026 B1 FR2948026 B1 FR 2948026B1
Authority
FR
France
Prior art keywords
dihydro
amino derivatives
triazine amino
triazine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0954976A
Other languages
English (en)
Other versions
FR2948026A1 (fr
Inventor
Didier Mesangeau
Xavier Leverve
Daniel Cravo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Merck Sante SAS
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Merck Sante SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Merck Sante SAS filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR0954976A priority Critical patent/FR2948026B1/fr
Priority to PCT/EP2010/060290 priority patent/WO2011006983A1/fr
Publication of FR2948026A1 publication Critical patent/FR2948026A1/fr
Application granted granted Critical
Publication of FR2948026B1 publication Critical patent/FR2948026B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
FR0954976A 2009-07-17 2009-07-17 Derives amines de dihydro-1,3,5-triazine Expired - Fee Related FR2948026B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0954976A FR2948026B1 (fr) 2009-07-17 2009-07-17 Derives amines de dihydro-1,3,5-triazine
PCT/EP2010/060290 WO2011006983A1 (fr) 2009-07-17 2010-07-16 Derives amines de dihydro-1,3,5-triazine pour le traitement du stress oxydatif

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0954976A FR2948026B1 (fr) 2009-07-17 2009-07-17 Derives amines de dihydro-1,3,5-triazine

Publications (2)

Publication Number Publication Date
FR2948026A1 FR2948026A1 (fr) 2011-01-21
FR2948026B1 true FR2948026B1 (fr) 2011-12-02

Family

ID=41478841

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0954976A Expired - Fee Related FR2948026B1 (fr) 2009-07-17 2009-07-17 Derives amines de dihydro-1,3,5-triazine

Country Status (2)

Country Link
FR (1) FR2948026B1 (fr)
WO (1) WO2011006983A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6041887B2 (ja) 2011-11-15 2016-12-14 ネステク ソシエテ アノニム 遠心作用により飲料を調製するための支持体及びカプセル、並びに遠心作用により飲料を調製するためのシステム及び方法
HUE028455T2 (en) 2011-11-15 2016-12-28 Nestec Sa Optically readable code carrier and capsule containing such code carrier for optical readability with improved readability
EP2594171B1 (fr) 2011-11-16 2014-04-16 Nestec S.A. Support et capsule pour préparer une boisson par centrifugation, système et procédé pour préparer une boisson par centrifugation
ES2611463T3 (es) 2013-09-30 2017-05-09 Nestec S.A. Soporte de código y cápsula para preparar una bebida por centrifugación, sistema y método para preparar una bebida por centrifugación
CN104739838B (zh) * 2014-09-30 2017-07-14 三峡大学 小分子抑制剂及在抑制鸟氨酸脱羧酶(odc)上的应用
FR3068601B1 (fr) * 2017-07-05 2021-02-19 Eric Joseph Marie Fulgence Janin Utilisation de l'imeglimine pour la prevention et/ou le traitement du carcinome hepatocellulaire

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2804113B1 (fr) * 2000-01-26 2004-06-18 Lipha Derives animes de dihydro-1,3,5-triazine et leurs applications en therapeutique
ES2423800T3 (es) * 2003-03-28 2013-09-24 Novartis Vaccines And Diagnostics, Inc. Uso de compuestos orgánicos para la inmunopotenciación
FR2853650B1 (fr) * 2003-04-10 2006-07-07 Merck Sante Sas Procede de dedoublement d'amines utiles pour le traitement de desordres associes au syndrome d'insulino-resistance
EP1749552A1 (fr) * 2005-07-29 2007-02-07 Neuropharma S.A. Utilisation de la collismycine et de ses dérivés en tant qu'inhibiteurs du stress oxydatif
FR2896159B1 (fr) * 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents sensibilisateurs a l'insuline.
AU2007286630A1 (en) * 2006-08-23 2008-02-28 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Derivatives of uric and thiouric acid for oxidative stress-related diseases
JP5485292B2 (ja) * 2008-12-12 2014-05-07 ポクセル・エスアーエス Ａｍｐｋ活性に関連する疾患を処置するためのテトラヒドロトリアジン化合物

Also Published As

Publication number Publication date
WO2011006983A1 (fr) 2011-01-20
FR2948026A1 (fr) 2011-01-21

Similar Documents

Publication Publication Date Title
LTPA2020002I1 (lt) Heterociklinis diamino karboksamido junginys
FR22C1024I2 (fr) Derives de pyridazinone
NL2000537A1 (nl) Aminederivaten.
BRPI0907563A2 (pt) Derivados de 4,5-di-hidro-xazol-2-il amina
ATE555107T1 (de) 2-aza-bicyclo-ä2,2,1-üheptan-derivate
IL216829A0 (en) Ureidophenyl substituted triazine derivatives, compositions comprising the same and uses thereof
BRPI0914662A2 (pt) derivados de triazinona substituída
IL216833A0 (en) Triazine derivatives, compositions comprising the same and uses thereof
IL216825A0 (en) Triazine derivatives, processes for producing the same, compositions comprising the same and uses thereof
BRPI0811280A2 (pt) Compostos amino-heterocíclicos
BRPI1013760A2 (pt) compostos anticâncer de amino pirimidina.
DE602008005634D1 (de) 1,1,1-trifluor-2-hydroxy-3-phenylpropan-derivate
IL216832A0 (en) Triazine derivatives, processes for producing the same, compositions comprising the same and uses thereof
BR112012007112A2 (pt) poliamida, composições e artigo
SMP200900065B (it) Derivati ciclizzati come inibitori di EG-5.
FR2928371B1 (fr) Derive de cysteine.
FR2902426B1 (fr) Derives de cinnamoyl-piperazine
BRPI0906357A2 (pt) Derivados de oxazepinopirimidona arilamida substituídos
BRPI0917446A2 (pt) derivados de acilaminobenzamida.
IL216827A0 (en) Benzyl substituted triazine derivatives, compositions comprising the same and uses thereof
FR2948026B1 (fr) Derives amines de dihydro-1,3,5-triazine
BRPI0811527A2 (pt) Derivados de arilamida pirimidona
IL216831A0 (en) Triazine derivatives, compositions comprising the same and uses thereof
FR2913022B1 (fr) Articles polyamides microcellulaires
ZA201006211B (en) Method for the production of 3,6-dihydro-1,3,5-triazine derivatives for metformin and paraldehtde derivatives

Legal Events

Date Code Title Description
TQ Partial transmission of property
ST Notification of lapse

Effective date: 20130329